FLICKR, EC/ECHO
An American nurse exposed to Ebola while caring for patients in Sierra Leone was today (December 11) admitted to the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. The patient will be treated by infectious disease and critical care specialists in a unit “specifically designed to provide high-level isolation capabilities,” the NIH said in a statement.
Meanwhile, a clinical trial of the rVSV-EBOV vaccine candidate now licensed to Merck & Co. has been put on hold at a Swiss hospital. Four of the 59 trial participants reported joint pains in their hands and feet. A research team at the University of Geneva Hospital plans to restart the study on January 5 after confirming that the side effects are “benign and temporary,” BBC News ...
